{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:42:33Z","timestamp":1790772153840,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ejphar.2015.08.016","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T16:06:24Z","timestamp":1439827584000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Why are second-generation H1-antihistamines minimally sedating?"],"prefix":"10.1016","volume":"765","author":[{"given":"Yawen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidra E.","family":"Sieck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter H.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.08.016_bib1","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","article-title":"P-glycoprotein: from genomics to mechanism","volume":"22","author":"Ambudkar","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2015.08.016_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1124\/dmd.31.3.312","article-title":"P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists","volume":"31","author":"Chen","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2015.08.016_bib3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","article-title":"Risk of first-generation H1-antihistamines: a GA2LEN position paper","volume":"65","author":"Church","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.ejphar.2015.08.016_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-013-3075-z","article-title":"The role of P-glycoprotein in CNS antihistamine effects","volume":"229","author":"Conen","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2015.08.016_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jps.20780","article-title":"Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro\/in vivo case studies","volume":"96","author":"Constantinides","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2015.08.016_bib6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0090-9556(24)15235-X","article-title":"OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine","volume":"27","author":"Cvetkovic","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2015.08.016_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1537-1891(02)00201-X","article-title":"Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood\u2013brain barrier","volume":"38","author":"Demeule","year":"2002","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-199528050-00006","article-title":"Pharmacokinetic\u2013pharmacodynamic relationships of H1-antihistamines","volume":"28","author":"Desager","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2015.08.016_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2125.2002.01611.x","article-title":"Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers","volume":"54","author":"Gandon","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/dmd.105.007211","article-title":"Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: Kp, Kp,u, and Kp,uu","volume":"34","author":"Gupta","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2015.08.016_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11094-010-0386-9","article-title":"Inverse agonists of H1-receptors as promising antiallergy agents (a review)","volume":"44","author":"Gushchin","year":"2010","journal-title":"Pharmaceut. Chem. J."},{"key":"10.1016\/j.ejphar.2015.08.016_bib12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/chir.20815","article-title":"Stereoselective and multiple carrier-mediated transport of cetirizine across Caco-2 cell monolayers with potential drug interaction","volume":"22","author":"He","year":"2010","journal-title":"Chirality"},{"key":"10.1016\/j.ejphar.2015.08.016_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2006.10.007","article-title":"A primer on the mechanics of P-glycoprotein the multidrug transporter","volume":"55","author":"Hennessy","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2015.08.016_bib14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1046\/j.1365-2222.2003.01769.x","article-title":"Consensus group on new-generation antihistamines (CONGA): present status and recommendation","volume":"33","author":"Holgate","year":"2003","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2015.08.016_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nri2262","article-title":"Treatment strategies for allergy and asthma","volume":"8","author":"Holgate","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1472-9725.2002.00030.x","article-title":"The choice of an H1-antihistamine for the 21st century","volume":"2","author":"Howarth","year":"2002","journal-title":"Clin. Exp. Allergy Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2015.08.016_bib17","first-page":"S27","article-title":"Antihistamines in drivers, aircrew and occupations of risk","volume":"23","author":"J\u00e1uregui","year":"2013","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature11448","article-title":"Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans","volume":"490","author":"Jin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2015.08.016_bib19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0091-6749(05)80246-5","article-title":"Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo","volume":"86","author":"Kalivas","year":"1990","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejps.2011.09.007","article-title":"Estimation of P-glycoprotein-mediated efflux in the oral absorption of P-gp substrate drugs from simultaneous analysis of drug dissolution and permeation","volume":"44","author":"Kataoka","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2015.08.016_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2133\/dmpk.21.308","article-title":"Transporter-mediated intestinal absorption of fexofenadine in rats","volume":"21","author":"Kikuchi","year":"2006","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2015.08.016_bib1001","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40261-013-0140-7","article-title":"Pharmacokinetic comparisons of bepotastine besilate and bepotastine salicylate in healthy subjects","volume":"33","author":"Kim","year":"2013","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ejphar.2015.08.016_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1254\/jjp.43.277","article-title":"Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay","volume":"43","author":"Kubo","year":"1987","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib23","series-title":"Goodman and Gillman's The Pharmacological Basis of Therapeutics","author":"Laurence","year":"2011"},{"key":"10.1016\/j.ejphar.2015.08.016_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.0954-7894.2002.01314.x","article-title":"H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects","volume":"32","author":"Leurs","year":"2002","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2015.08.016_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/pro.2387","article-title":"Refined structures of mouse P-glycoprotein","volume":"23","author":"Li","year":"2014","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejphar.2015.08.016_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1152\/physiol.00046.2006","article-title":"Structure and function of ABC transporters","volume":"22","author":"Linton","year":"2007","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.ejphar.2015.08.016_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1124\/jpet.107.130294","article-title":"Progress in brain penetration evaluation in drug discovery and development","volume":"325","author":"Liu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.08.016_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/md12010525","article-title":"Marine natural products with P-glycoprotein inhibitor properties","volume":"12","author":"Lopez","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejphar.2015.08.016_bib29","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/bmj.320.7243.1184","article-title":"Sedation with \u201cnon-sedating\u201d antihistamines: four prescription-event monitoring studies in general practice","volume":"320","author":"Mann","year":"2000","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2015.08.016_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(24)36413-4","article-title":"Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)","volume":"280","author":"Merlos","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.08.016_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2012.04.034","article-title":"Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes","volume":"161","author":"Montesinos","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejphar.2015.08.016_bib32","first-page":"432","article-title":"Blood\u2013brain barrier in vitro models as tools in drug discovery: assessment of the transport ranking of antihistaminic drugs","volume":"67","author":"Neuhaus","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejphar.2015.08.016_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11095-006-9149-4","article-title":"Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein","volume":"24","author":"Obradovic","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2015.08.016_bib34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1124\/dmd.105.007559","article-title":"Effect of P-glycoprotein on intestinal adsorption and brain penetration of antiallergic agent bepotastine besilate","volume":"34","author":"Ohashi","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2015.08.016_bib35","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1529\/biophysj.105.077743","article-title":"Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism","volume":"90","author":"Omote","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2015.08.016_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/13651501.2014.907919","article-title":"Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety","volume":"18","author":"Ozdemir","year":"2014","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.ejphar.2015.08.016_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/187152308783769212","article-title":"Use of antihistamines in allergic rhinitis","volume":"7","author":"Pata","year":"2008","journal-title":"Antiinflamm. Antiallergy Agents Med. Chem."},{"key":"10.1016\/j.ejphar.2015.08.016_bib1002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12948-015-0008-x","article-title":"Bilastine: new insight into antihistamine treatment","volume":"13","author":"Ridolo","year":"2015","journal-title":"Clin. Mol. Allergy"},{"key":"10.1016\/j.ejphar.2015.08.016_bib1003","first-page":"1999","article-title":"Safety profile of bilastine: 2nd generation H1-antihistamines","volume":"16","author":"Scaglione","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2015.08.016_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/chir.20400","article-title":"Stereoselective regulation of MDR1 expression in Caco-2 cells by cetirizine enantiomers","volume":"19","author":"Shen","year":"2007","journal-title":"Chirality"},{"key":"10.1016\/j.ejphar.2015.08.016_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00204-010-0587-8","article-title":"In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells","volume":"85","author":"Silva","year":"2011","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0091-6749(84)90486-X","article-title":"The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine","volume":"73","author":"Simons","year":"1984","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0091-6749(95)70173-7","article-title":"Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria","volume":"95","author":"Simons","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2125.2001.01471.x","article-title":"Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second generation antihistamine, and chlorpheniramine, a classical antihistamine","volume":"52","author":"Tagawa","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/10611860008997914","article-title":"Blood\u2013brain barrier transport of H1-antagonist ebastine and its metabolite carebastine","volume":"8","author":"Tamai","year":"2000","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ejphar.2015.08.016_bib44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2125.2008.03143.x","article-title":"Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin","volume":"65","author":"Tashiro","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl 3","key":"10.1016\/j.ejphar.2015.08.016_bib45","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1046\/j.1365-2222.1999.00003.x-i1","article-title":"Why are non-sedating antihistamines non-sedating?","volume":"29","author":"Timmerman","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2015.08.016_bib46","first-page":"1080","article-title":"Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein","volume":"29","author":"Wang","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2015.08.016_bib47","doi-asserted-by":"crossref","first-page":"13386","DOI":"10.1073\/pnas.1309275110","article-title":"Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain","volume":"110","author":"Ward","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2015.08.016_bib48","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jacc.2013.02.058","article-title":"The P-glycoprotein transport system and cardiovascular drugs","volume":"61","author":"Wessler","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2015.08.016_bib49","first-page":"59","article-title":"Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects","volume":"44","author":"Yamaguchi","year":"1994","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejphar.2015.08.016_bib50","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clpt.2004.08.002","article-title":"A variant 2677a allele of the MDR1 gene affects fexofenadine disposition","volume":"76","author":"Yi","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2015.08.016_bib51","first-page":"715","article-title":"Pharmacokinetics of loratadine and its active metabolite descarboethoxyloratadine in healthy Chinese subjects","volume":"24","author":"Zhang","year":"2003","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2015.08.016_bib52","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","article-title":"Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition","volume":"38","author":"Zhou","year":"2008","journal-title":"Xenobiotica"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915301904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915301904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T01:03:21Z","timestamp":1748567001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915301904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":55,"alternative-id":["S0014299915301904"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.08.016","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why are second-generation H1-antihistamines minimally sedating?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}